Eli Lilly and Company Parkinson's Drug Pulled from US market, FDA Says

Published: Mar 30, 2007

WASHINGTON, March 29 (Reuters) - U.S. health officials withdrew the Parkinson's disease drug pergolide from the market on Thursday, citing a history of safety concerns that include potentially fatal heart valve damage.

>>> Discuss This Story

Back to news